Who to call at SpyGlass Pharma, Inc., and when
Fundz watches for the moments SpyGlass Pharma, Inc. starts buying, and tells you who to reach.
- An alert the day SpyGlass Pharma, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at SpyGlass Pharma, Inc., from your own LinkedIn network
SpyGlass Pharma, Inc.
The company reported another event it considers important. An 8-K is the notice a US public company must file within four business days of a major event.
spyglassophthalmics.comAI Executive Summary
AI-powered analysis of 8-K filing content
SpyGlass Pharma acquired Advanced Vision Science, Inc. (AVS) from Santen Holdings US for $13 million on October 1, 2026, vertically integrating its intraocular lens supply chain while maintaining a supply and distribution agreement with the parent company in Japan.
Key Takeaways
SpyGlass acquired 100% of AVS, a former supplier of intraocular lenses under the Eternity brand, for $13 million in a stock purchase agreement
AVS will continue manufacturing and supplying intraocular lens products to Santen Pharmaceutical under an Amended and Restated Supply and Distribution Agreement with exclusive Japan distribution right
3 more takeaways
Filing Overview
What This Means
SpyGlass Pharma, Inc. filed with the SEC. Fundz turns 8-K material events into an alert with the right executive attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
4 screens from a live account. No signup.